---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-009272"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2022-04-06T23:59:59+00:00"
generated_at: "2026-06-26T09:16:04.927001+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical appoints Rachel Vaknin as CFO, replacing David Ben Naim effective April 1, 2022

## Summary
- David Ben Naim resigned as CFO effective April 1, 2022; Rachel Vaknin appointed as successor.
- Vaknin joined as VP Finance in Jan 2022; previously CFO at Imagry and FP&A manager at Mellanox.
- Vaknin receives base salary NIS32,000/mo + NIS8,000 global comp, annual bonus up to 20% of salary, and options for 20,000 shares.

## SEC filing metadata
- accession: 0001493152-22-009272
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2022-04-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315222009272/0001493152-22-009272-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315222009272/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-009272
- JSON: https://secwatch.observer/filing/0001493152-22-009272.json
- Plain text: https://secwatch.observer/filing/0001493152-22-009272.txt

## Key facts
- Executive change
  Rachel Vaknin was appointed as Chief Financial Officer at Microbot Medical Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: As of April 1, 2022, the Company appointed Rachel Vaknin, age 43, as its Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/883975/000149315222009272/0001493152-22-009272-index.htm
- Executive change
  David Ben Naim resigned as Chief Financial Officer at Microbot Medical Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: As of April 1, 2022, David Ben Naim, the Chief Financial Officer of Microbot Medical Inc. (the “Company”), resigned from his position with the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/883975/000149315222009272/0001493152-22-009272-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.